Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma

23Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This review will focus on recent knowledge related to circulating autoantibodies (AAbs) to tumor-associated antigens (TAAs) in epithelial ovarian carcinoma. So far, the following TAAs have been identified to elicit circulating AAbs in epithelial ovarian carcinoma: p53, homeobox proteins (HOXA7, HOXB7), heat shock proteins (HSP-27, HSP-90), cathepsin D, cancer-testis antigens (NY-ESO-1/LAGE-1), MUC1, GIPC-1, IL-8, Ep-CAM, and S100A7. Since AAbs to TAAs have been identified in the circulation of patients with early-stage cancer, it has been speculated that the assessment of a panel of AAbs specific for epithelial ovarian carcinoma TAAs might hold great potential as a novel tool for early diagnosis of epithelial ovarian carcinoma. © 2009 B. Piura and E. Piura.

Cite

CITATION STYLE

APA

Piura, B., & Piura, E. (2009). Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma. Journal of Oncology. https://doi.org/10.1155/2009/581939

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free